Loading…
NCT02970877 - Allogenic Fecal Microbiota Transplantation (FMT) vs Autologous FMT & Adiposity / Obesity is a randomized clinical phase II treatment trial to study Allogenic Fecal Microbiota Transplantation (FMT) or Autologous FMTin patients with morbidly obese (BMI >40 kg/m² or BMI >35-40 kg/m² with other severe weight loss responsive comorbidities)
Change in Insulin Resistance Compared to Baseline
For NCT02970877 - Allogenic Fecal Microbiota Transplantation (FMT) vs Autologous FMT & Adiposity / Obesity, as of February 2026 there is no yet publicly available full results article
…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!